文献速递主动脉疾病

基于人群的主动脉夹层、壁内血肿和穿透性主动脉溃疡的主动脉相关结局评估

Population-Based Assessment of Aortic-Related Outcomes in Aortic Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer.
PubMed 文献 · Ann Vasc Surg · 2020-06-17

该研究基于明尼苏达州奥姆斯特德县1995至2015年133例主动脉夹层、壁内血肿或穿透性主动脉溃疡患者,与年龄性别匹配的人群参照组比较,发现患者主动脉死亡、后续主动脉事件、主动脉干预及新发主动脉瘤的风险均显著升高,且急性期后风险持续存在。

要点

  • 主动脉夹层/壁内血肿/穿透性主动脉溃疡患者主动脉死亡风险显著高于人群参照组(调整HR 184.7)。
  • 38%患者发生后续主动脉事件,风险持续至急性期后(调整HR 10.8)。
  • 新发胸/腹主动脉瘤风险显著增加(调整HR 10.9和8.3)。

核心结论

  • 主动脉夹层、壁内血肿和穿透性主动脉溃疡患者面临显著的主动脉死亡、任何主动脉事件、主动脉干预及新发主动脉瘤风险,即使急性期(诊断后14天内)无并发症,风险仍持续存在。

研究设计与样本

  • 回顾性队列研究,纳入1995至2015年明尼苏达州奥姆斯特德县133例主动脉夹层、壁内血肿或穿透性主动脉溃疡患者,并与年龄性别匹配的人群参照组按3:1比例比较,采用Cox比例风险回归调整合并症。

主要发现

  • 133例患者中57%为男性,平均年龄71.8岁(标准差14),中位随访10年;73例死亡中23例(32%)为主动脉相关。
  • 估计无主动脉死亡生存率在5年、10年和15年分别为84%、80%和77%。
  • 排除诊断后14天内的主动脉事件/干预后,患者任何主动脉事件风险(调整HR 10.8;95%CI 3.9-29.8;P<0.001)和主动脉干预风险(调整HR 9.6;95%CI 3.4-26.8;P<0.001)仍增加。
  • 在有随访影像的受试者中,患者新发胸主动脉瘤(调整HR 10.9;95%CI 5.4-21.7;P<0.001)和腹主动脉瘤(调整HR 8.3;95%CI 4.1-16.7;P<0.001)风险显著增加;排除诊断后14天内形成的动脉瘤后,风险仍增加(胸主动脉瘤调整HR 6.2;95%CI 1.8-21.1;P=0.004;腹主动脉瘤调整HR 2.8;95%CI 1.0-7.6;P=0.040)。

临床怎么用

  • 对主动脉夹层、壁内血肿和穿透性主动脉溃疡患者,即使急性期无并发症,也应长期监测主动脉事件和新发动脉瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the study was to analyze aortic-related outcomes after diagnosis of aortic dissection (AD), intramural hematoma (IMH), and penetrating aortic ulcer (PAU) from a population-based approach. METHODS: Retrospective review of an incident cohort of AD, IMH, and PAU patients in Olmsted County, Minnesota from 1995 to 2015. Primary end point was aortic death. Secondary end points were subsequent aortic events (aortic intervention, new dissection, or rupture not present at presentation) and first-time diagnosis of an aortic aneurysm. Outcomes were compared with randomly selected population referents matched for age and sex in a 3:1 ratio using Cox proportional hazards regression adjusting for comorbidities. RESULTS: Among 133 patients (77 AD, 21 IMH, and 35 PAU), 57% were males, and mean age was 71.8 years (standard deviation, 14). Median follow-up was 10 years. Of 73 deaths among AD/IMH/PAU patients, 23 (32%) were aortic-related. Estimated freedom from aortic death was 84%, 80%, and 77% at 5, 10, and 15 years. There were no aortic deaths among population referents (adjusted hazard ratio [HR] for aortic death in AD/IMH/PAU, 184.7; 95% confidence interval [95% CI], 10.3-3,299.2; P < 0.001). Fifty (38%) AD/IMH/PAU patients had a subsequent aortic event (aortic intervention, new dissection, or rupture), whereas there were 8 (2%) aortic events among population referents (all elective aneurysm repairs; adjusted HR for any aortic event and aortic intervention in AD/IMH/PAU patients, 33.3; 95% CI, 15.3-72.0; P < 0.001 and 31.5; 95% CI, 14.5-68.4; P < 0.001, respectively). After excluding aortic events/interventions ≤14 days of diagnosis, AD/IMH/PAU patients remained at increased risk of any aortic event (adjusted HR, 10.8; 95% CI, 3.9-29.8; P < 0.001) and aortic intervention (adjusted HR, 9.6; 95% CI, 3.4-26.8; P < 0.001). Among those subjects with available follow-up imaging, the risk of first-time diagnosis of aortic aneurysm was significantly increased for AD/IMH/PAU patients when compared with population referents (adjusted HR, 10.9; 95% CI, 5.4-21.7; P < 0.001 and 8.3; 95% CI, 4.1-16.7; P < 0.001 for thoracic and abdominal aneurysms, respectively) and remained increased when excluding aneurysms that formed within 14 days of AD/IMH/PAU (adjusted HR, 6.2; 95% CI, 1.8-21.1; P = 0.004 and 2.8; 95% CI, 1.0-7.6; P = 0.040 for thoracic and abdominal aneurysms, respectively). CONCLUSIONS: AD/IMH/PAU patients have a substantial risk of aortic death, any aortic event, aortic intervention, and first-time diagnosis of aortic aneurysm that persists even when the acute phase (≤14 days after diagnosis) is uncomplicated. Advances in postdiagnosis treatment are necessary to improve the prognosis in these patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Weiss S, Sen I, Huang Y, et al. Population-Based Assessment of Aortic-Related Outcomes in Aortic Dissection, Intramural Hematoma, and Penetrating Aortic Ulcer. Ann Vasc Surg. 2020. PMID: 32561245. doi:10.1016/j.avsg.2020.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。